A clinical study of latiglutenase as a treatment for symptom reduction for celiac disease
Ended Cooperative Agreement Awarded Last action
- Award ID
- U44AI134590
- Recipient
-
Immunogenx, Inc. UEI DHJSMHJ9BJE5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,789,282
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Funding
-
- $4,790,664.00 Federal
- $998,618.00 Non-federal
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $728,593 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $82,973 | $0 | |
| Amendment | $82,973 | $0 | |
| Amendment | $200,524 | $0 | |
| Amendment | $200,524 | $0 | |
| Amendment | $200,524 | $0 | |
| Amendment | $998,618 | $0 | |
| Amendment | $998,618 | $998,618 | |
| Amendment | -$82,973 | $0 | |
| Amendment | $82,973 | $0 | |
| Amendment | $998,228 | $0 | |
| Amendment | $0 | $0 | |
| Original award | $299,089 | $0 |
Show all 14
Quick answers
Who received award U44AI134590?
U44AI134590 was awarded to Immunogenx, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 8, 2019.
How much is award U44AI134590 worth?
$5,789,282 has been obligated on U44AI134590: $4,790,664 in federal funding and $998,618 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award